The DINGO dataset: a comprehensive set of data for the SAMPL challenge by Newman, Janet et al.
The DINGO dataset: a comprehensive set of data
for the SAMPL challenge
Janet Newman • Olan Dolezal • Vincent Fazio •
Tom Caradoc-Davies • Thomas S. Peat
Received: 24 October 2011/Accepted: 8 December 2011/Published online: 21 December 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Part of the latest SAMPL challenge was to
predict how a small fragment library of 500 commercially
available compounds would bind to a protein target. In
order to assess the modellers’ work, a reasonably com-
prehensive set of data was collected using a number of
techniques. These included surface plasmon resonance,
isothermal titration calorimetry, protein crystallization and
protein crystallography. Using these techniques we could
determine the kinetics of fragment binding, the energy of
binding, how this affects the ability of the target to crys-
tallize, and when the fragment did bind, the pose or ori-
entation of binding. Both the ﬁnal data set and all of the
raw images have been made available to the community for
scrutiny and further work. This overview sets out to give
the parameters of the experiments done and what might be
done differently for future studies.
Keywords X-ray crystallography  Surface plasmon
resonance  Isothermal titration calorimetry  Modelling 
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Introduction
We approached this in a signiﬁcantly different way than a
‘normal’ fragment screening campaign in the sense that the
data set was to be complete (or as complete as physically
possible). To elaborate, in a ‘normal’ fragment screening
campaign, it is usual to have a fairly short timeline, so the
project is set up to screen the fragments as quickly as
possible using the most effective method ﬁrst, and then use
subsequent methods for veriﬁcation and to determine the
other parameters of value. For example, in our laboratory,
we will typically screen the fragment set using SPR (taking
about 1 week) and then only do protein crystallography on
the hits from the SPR. We would only use ITC on those
that were tight binders (better than 200 lM) and where we
wanted veriﬁcation of the binding energy. We would
generally soak all fragments into pre-formed crystals and
not attempt doing co-crystallization of compounds with the
protein. In contrast, for the SAMPL project, it was one of
the major goals of the project to have a complete data set
for the modelling community to go back to and reference.
For the DINGO data set, we systematically soaked every
fragment of the set into the protein crystals and collected
data sets for each of these complexes. In addition, co-
crystallization of the target protein with fragments was
undertaken as an orthogonal approach. The target chosen
for the SAMPL challenge requires an inhibitor in order for
crystallisation to occur, so the presence or absence of
crystals with any given fragment in co-crystallisation trials
is predictive of whether that fragment binds to the protein
target. The SPR was done several times and dosage curves
were also done several times on all those compounds that
were ‘hits’.
Bovine pancreatic trypsin [1] was used as the target for
several reasons. It is easily obtainable from commercial
vendors; the crystallographic community has studied it
rather thoroughly; it is a protease that is similar to other
proteases of human health interest; and there is a body of
literature that supports a prospective challenge such as
SAMPL, including known positive controls that could be
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500 fragment library was chosen as it was commercially
available and we had tested it against some other targets
and knew that it had fragments that could bind to trypsin.
After starting the project, it became apparent that our
choices did have some drawbacks. Trypsin is a protease
that will self-proteolyze, so is unstable over time for all of
our experiments (ITC, crystallization, etc.). The Maybridge
500 fragment library has some compounds that are insol-
uble under the conditions we used in several of the tech-
niques where aqueous solubility has signiﬁcant advantages
(e.g. ITC). And ﬁnally, in our effort to be comprehensive,
trying to collect X-ray crystallographic data sets of 500
different fragments soaked into trypsin crystals required
the growth of well over 3,000 ‘production’ crystals and the
collection of well over 1,000 data sets at the Australian
Synchrotron [5].
Methods
All SPR Experiments were performed using a Biacore
T100 instrument (GE Healthcare). Trypsin was immobi-
lized onto a CM5 chip using standard amine coupling
chemistry. Benzamidine was used as a positive control to
validate trypsin activity on the chip. The binding capacity
of immobilized trypsin (Rmax) was increased by purifying
the protein using size exclusion chromatography and
immobilizing the protein in the presence of 5 mM ben-
zamidine and up to 20 mM CaCl2. Typically in SPR
experiments, a gradual decrease in analyte binding capacity
(Rmax) by the immobilized protein is indicative of protein
decay. CaCl2 is a structural inhibitor of trypsin [6] and its
presence was observed to prolong the activity of the
immobilized surface.
For the fragment screening experiments, two of the four
channels (ﬂow cells 2 and 4) on the chip surface had
trypsin immobilized. One trypsin surface was ‘aged’ in that
it was put down 24 h prior to application of the second
trypsin surface to see what the effect of this would be on
binding. Our expectation, which was borne out, was that
this aged protein would have less binding capacity and we
should see a comparably lower response in this channel for
real hits. Bovine carbonic anhydrase II (CAII) was
immobilized in ﬂow cell 3 where it served as a negative
protein control. Flow cell 1 was left intact and used as a
reference (blank) surface. Maybridge library fragments,
previously prepared at 100 mM in neat DMSO (master
stocks), were diluted into SPR running buffer (50 mM
HEPES pH 7.4, 150 mM NaCl, 0.05% (v/v) Tween-20,
1m MC a C l 2 and 5% [v/v] DMSO) to 100 lM and injected
over the chip surfaces. To assess the stability and repro-
ducibility of the assay, positive controls (benzamidine and
p-amino-benzenesulfonamide) were injected several times
throughout the screening experiment. Three hundred and
eighty-four fragments in a 384-well plate were screened
within approximately 30 h. Remaining compounds were
screened later using a similar screening approach. Scrubber
(http://www.biologic.com.au) was utilized for data pro-
cessing and analysis. SPR signals were referenced against
the blank surface and further corrected for DMSO refrac-
tive index changes (excluded volume effect). Binding data
were normalized for the molecular weight of the fragments.
The normalization scheme of Giannetti et al. [7] was fur-
ther applied to the processed data based on the maximal
binding response (Rmax) determined from ﬁtting the con-
trol compound sensorgrams. Compounds showing unde-
sirable SPR binding characteristics similar to those
described previously [7] were removed from the screening
data.
The selected top 20 hits were further analysed using
dosage experiments. These were performed at 20 Cb y
injecting a concentration series in two-fold dilutions
(C = 4–256 lM). To estimate binding afﬁnities (equilib-
rium dissociation constant, KD), binding responses at
equilibrium (Req) were ﬁt to a 1:1 steady state afﬁnity
model (available within Scrubber) which utilizes a non-
linear least squares regression method to ﬁt the Langmuir
adsorption isotherm (Req = Rmax*KD/[KD ? C]) to each
data set. A normalized saturation response (Rmax), derived
using the reference compound, was applied to the respon-
ses obtained with fragment hits that, due to solubility and
chip surface artefact issues, could not be injected at or near
saturating concentrations. A SPR dosage experiment for
benzamidine binding to immobilized trypsin is shown in
Fig. 1a. Interestingly, a marginally higher afﬁnity was
consistently estimated in the presence of CaCl2 where the
KD for benzamidine binding to trypsin was measured to be
*7 lM whereas in the absence of CaCl2,K D was esti-
mated to be approximately *15 lM (data not shown).
To further conﬁrm our SPR and crystallography hits, iso-
thermal titration calorimetry experiments (ITC) were per-
formed using a MicroCal Auto-iTC200 (GE Healthcare).
Trypsin solutions were freshly prepared in 50 mM Tris–HCl,
10 mMCaCl2,pH8.0anddialysedovernightagainstthesame
buffer at 4 C. Prior to titration, the trypsin solution was
spikedwithDMSOtomatchthe5%(v/v)DMSOinthesmall
molecule solution. Fragment solutions (concentration in the
range 1.8–16 mM, depending on the speciﬁc inhibitor) were
titratedintothestirred(1,000r.p.m.)cell(300 lL)containing
trypsin solution (0.16–1.6 mM). Data were analysed using
Origin software by ﬁtting a single-site binding isotherm that
yields DH (enthalpy of binding) and KA (binding constant).
Thesetitrationexperimentsonlyallowedforestimationofthe
tightest binding fragments from the SPR hit list
(KD\300 lM, Table 1). Weaker binding fragments could
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tions of both protein and compound required to generate
sufﬁcientheatthatcanbedetectedinthemicrocalorimeter.A
more detailed description of the SPR and ITC experiments,
alongwiththePDBcoordinatesofthefragmenthitstructures,
will be published in the near future (manuscript in
preparation).
All of the crystallization experiments were performed at
the Collaborative Crystallisation Centre (C3) at CSIRO in
Melbourne, Australia. Drops were set up in two subwell
sitting drop plates (SD-2, IDEX Corp) using a Phoenix
robot (Art Robbins Industries) with 50 lL of crystallant in
the reservoir and droplets consisting of 300 nL of the
reservoir and 195 nL of the protein sample and 5 nL of
seed stock [8]. Only one of the two crystallisation subwells
was utilised for the initial crystallisation. A robotic pro-
cedure using a Mosquito robot (TTP) was developed to
place a mixture of fragment and a cryoprotectant onto the
both the crystallisation droplet and the unused subwell in
the sitting drop plates [9]. The second subwell was used as
part of the 2 step soaking procedure to make sure the
fragments had a chance to displace the benzylamine in
the crystals. After allowing the fragments to soak into the
crystals for 24–48 h, the crystals were transferred manually
to the fresh fragment/cryoprotectant solution in the second
subwell and allowed to soak an additional 24–48 h. Crys-
tals were gently removed using mylar loops (MiTeGen)
mounted in copper pins (Crystal Positioning Systems,
USA) and cryo-cooled in liquid nitrogen and placed in a 96
hole cassette that was kept submerged in liquid nitrogen
until the individual pin with the crystal of interest was
placed in the X-ray beam at the Australian Synchrotron. At
least two crystals were harvested for each of the soaks and
data sets were attempted for both in all cases. 181 frames of
data, each one a 1 oscillation with 1–3 s of exposure, were
taken for each crystal. All of the data sets were initially
processed using a script called Jigsaw [5] (available upon
request) that uses the following crystallographic programs
to automatically index, scale, do molecular replacement, an
initial round of reﬁnement and then try to place a ligand in
the excess density of the active site (when present): XDS
[10], Pointless (CCP4) [11], SCALA (CCP4) [11], Phaser
(CCP4) [11], Refmac (CCP4) [11], Flynn (OpenEye) [12].
Coot was used to visualize the model and electron density
as well as manually rebuild the model where there were
changes [13].
Discussion
This was a project which could not have been attempted
without a lot of recent (and expensive) tools: for example,
automation in crystallogenesis, X-ray data collection and
computing. It is notable that the technology for one of the
major techniques used in this project, surface plasmon
resonance, only became available in the early 1990s. In all,
Fig. 1 a–c NormalizedSPRsensorgramsshowingbenzamidine(a)a n d
CC 00813 (b) binding to immobilized trypsin. Both compounds were
injected as an eight-membered twofold dilution series (including ‘zero
buffer blank’) with a top concentration of 160 lM for benzamidine and
256 lMforCC00813.Diagramincshowﬁtsofthebindingresponsesat
equilibrium (t = 50–55 s, plotted against compound concentration) to a
1:1 steady state afﬁnity model. As CC00813 failed to reach a maximal
binding response (Rmax) at the top injected concentration (256 lM), its
afﬁnity (KD = 466 lM) was estimated using Rmax values determined
from a benzamidine binding ﬁt
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123Table 1 Values given in the columns for SPR and ITC are
micromolar; NA means not attempted; values for the co-crystalliza-
tion are the number of crystals seen out of the number of successful
drops set up (in some cases the drop was not set down properly by the
robotics); for fragment density, yes means that there was clean and
clear density for the fragment, no means that there was no fragment
density or that it wasn’t clear
Maybridge
#
Mol
wt.
SPR
afﬁnity
(lM)
ITC
afﬁnity
(lM)
Co-
crystals
found
Soaked
fragment
density
Co-crystal
fragment density
2D
CC 33513 242.1 24 33.9 94 of 94 Yes Yes
CC 12313 199.7 31 43.1 96 of 96 Yes Yes
CC 38513 176.3 71 180.7 91 of 95 Yes Yes
CC 00413 215.7 136 157 96 of 96 NA Yes
2
CC 11513 196.3 153 163.2 26 of 34 Yes Yes
2
CC 21913 172.2 236 (old)
40 (new)
97.5 41 of 96 Yes Yes
2
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123to assemble the experimental underpinnings for this project
took ﬁve domain experts close to 2 years, and required
equipment that was millions of dollars to purchase and run.
This is excluding the cost of the Australian Synchrotron,
where the equivalent of about a month of continuous beam-
time was required to collect the X-ray diffraction data for this
challenge. If we were to attempt this same amount of data
collection on a standard X-ray home source it would take
closer to a decade of continuous beamtime to collect the same
amount of data. Similarly, about 200 96-well crystallisation
plates were set up during the course of this experiment; by
hand, assembling that many experiments would take close to
3 working months, and that is without even taking a peek at
the experimental results once they were set up.
The enormity of the project is quite obvious to most
experimentalists, and explains why this type of challenge
has not been taken on previously; the modelling commu-
nity has been relying on retrospective analyses in part
because the prospective data are so expensive to obtain.
These experimental data are not perfect: there is ‘real
world’ noise in the data—machines break, chemicals
degrade, data get misplaced (despite best efforts) and then
the reality is that data from different biophysical techniques
cannot be cleanly compared to each other. The use of
amine coupling techniques to prepare SPR chips precludes
the use of Tris buffers to attach the protein to the chip. The
requirement for cryoprotection of protein crystals results in
protein structures with blobs of extra density which are
from the ethylene glycol cryoprotectant rather than any
fragment. There are numerous examples where the details
of experimental setup are where the difﬁculties lie.
Lookingatthedifferencesinthetechniques,weseethatthe
pHandbufferwasdifferentforeach:SPRused50 mMHepes
pH 7.4, 150 mM NaCl, 0.05% Tween P20, 20 mM
CaCl2 ? 5% DMSO for the fragment; ITC used 50 mM Tris
pH 8.0, 10 mM CaCl2 ? 5% DMSO for the fragment; and
crystallization used 22.5% w/v PEG 3350, 0.18 M
(NH4)2SO4,0.12 MNaSCN,0.09 MBis–TrispH5.5,0.01 M
Tris pH8.5,which gave a ﬁnalpHof5.8. DMSO was usedin
all cases as the fragments were solubilized in neat DMSO at
the start. It should be noted that the crystals obtained for
soaking were in space group P212121, whereas most of the
crystal structures determined for the co-crystallization with
fragmentswerefoundinP312.Thisisduetothefactthatwhen
DMSO ispresent duringthe crystallizationprocess,the space
group tends to fall into the trigonal space group. There may
also be some inﬂuence due to a pH change- the co-crystal
experiments were done at pH 7.0 instead of pH 5.8. We have
typically found that SPR is a reliable method for estimating
bindingconstantsoffragmentsuptoKD = 250–500 lM,but
beyond this level the error associated with the measurements
can become signiﬁcant. In particular, the insolubility of
fragments in SPR compatible buffers and at high fragment
concentrations, can cause chip surface interaction artefacts,
Table 1 continued
Maybridge
#
Mol
wt.
SPR
afﬁnity
(lM)
ITC
afﬁnity
(lM)
Co-
crystals
found
Soaked
fragment
density
Co-crystal
fragment density
2D
CC 35913 205.3 271 185.9 54 of 91 No Yes
2
CC 32913 173.2 400 NA 9 of 96 Yes NA
2
CC 00813 185.7 466 NA 12 of 96 Yes No
2
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123and this prevents fragment injections at or near the saturating
concentrations required for accurate afﬁnity estimations. As
discussed previously, by applying a normalization scheme
based on the saturation response from a positive control it is
possible to estimate afﬁnities without achieving saturation
(Fig. 1b,c).UsingthisapproachweattemptedtoestimateKD
up to 1 mM values, but as can be seen in Table 1, the corre-
spondence between the SPR and crystallography methods
breaksdownbeyond300 lMandwesaw nofragmentsinthe
crystal structures beyond the 500 lMb a r r i e r .
Although we were limited by the solubility and weak
binding of the fragments in the ITC experiments, the cor-
relation between the SPR and ITC is relatively good (see
Table 1). For most of the SPR hits better than 300 lM, we
have multiple X-ray data sets to conﬁrm the position of the
ligand found in the binding site. All of the ligands found to
date sit in the same binding site as the benzamidine and
benzylamine controls and all have a primary amine that
binds to the Asp189 residue of trypsin (see Fig. 2). Trypsin
is a rather rigid molecule and besides a few rotomer
changes of side chains, there are no large loop or domain
movements upon binding these fragments.
We conclude from looking at our experimental results
that the rigidity of the target limited the hit rate of fragment
binding, and that an experienced protease expert would
have looked at the fragment library and picked out the
likely binders simply by choosing molecules that look
somewhat akin to well known protease inhibitors such as
benzamidine. This would have probably taken an after-
noon, rather than the 2 years to collect the experimental
results! However, despite the ‘obviousness’ of the results in
retrospect, there was no modeling technique that found or
ranked all the experimental hits correctly, showing clearly
the value of this work—without guides to let us know when
Fig. 2 a CC 00413 bound to
trypsin in a co-crystallization
experiment. Data to 1.90 A ˚,
space group P312. Asp189 is
seen in the upper right of the
ﬁgure. The protein carbon atoms
are coloured green whereas the
carbon atoms of the fragment
are coloured in gray. A 2Fo-Fc
electron density map is shown
as a blue mesh. b CC 33513
soaked into trypsin crystals
(space group P212121),
resolution 1.4 A ˚. For clarity, the
atom attached to the benzene
ring and colored a deep red,i s
Br. c CC 32913 soaked into the
trypsin crystals (space group
P212121, resolution 1.4 A ˚).
d Model and electron density
for benzamidine, one of the two
control compounds used in this
experiment. All ﬁgures are in
approximately the same
orientation with Asp189 in the
upper right hand corner of the
ﬁgures (about 2 o’clock)
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123an approach/method isn’t working, that method cannot
advance. We are glad that the experiments have opened up
new directions for modeling development, and in future
years (when the memory of this data collection has faded)
we may be able to do this again to see how far modeling
has progressed.
Acknowledgments We thank Kim Branson and Anthony Nicholls
for the opportunity to contribute to the SAMPL challenge; to Matt
Geballe and Vijay Pande for organizing the recent SAMPL meeting;
our managers (Tim O’Meara, Tim Adams and Paul Savage) for
supporting us; and most importantly the Australian Synchrotron for
giving us the beam time to collect all of the data sets.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Kunitz M, Northrop JH (1931) Isolation of protein crystals pos-
sessing tryptic activity. Science 73:262–263
2. Rauh D et al (2002) Trypsin mutants for structure-based drug
design: expression, refolding and crystallisation. J Biol Chem
383:1309–1314
3. Markwardt F, Landmann H, Walsmann P (1968) Comparative
studies on the inhibition of trypsin, plasmin, and thrombin by
derivatives of benzylamine and benzamidine. Eur J Biochem
6:502–506
4. Stubbs MT, Huber R, Bode W (1995) Crystal structures of factor
Xa speciﬁc inhibitors in complex with trypsin: structural grounds
for inhibition of factor Xa and selectivity against thrombin. FEBS
Lett 375:103–107
5. Newman J, Fazio VJ, Caradoc-Davies TT, Branson K, Peat TS
(2009) Practical aspects of the SAMPL challenge: providing an
extensive experimental data set for the modeling community.
J Biomol Screen 14:1245–1250
6. McDonald MR, Kunitz M (1941) The effect of calcium and other
ions on the autocatalytic formation of trypsin from trypsinogen.
J Gen Physiol 25:53–73
7. Giannetti AM, Koch BD, Browner MF (2008) Surface plasmon
resonance based assay for the detection and characterization of
promiscuous inhibitors. J Med Chem 51:574–580
8. Luft JR, DeTitta GT (1999) A method to produce microseed
stock for use in the crystallization of biological macromolecules.
Acta Crystallogr D55:988–993
9. Newman J, Pham TM, Peat TS (2008) Phoenito experiments:
combining the strengths of commercial crystallization automa-
tion. Acta Crystallogr F64:991–996
10. Kabsch W (1993) Automatic processing of rotation diffraction
data from crystals of initially unknown symmetry and cell con-
stants. J Appl Crystallogr 26:795–800
11. The CCP4 suite: programs for protein crystallography (1994)
Acta Crystallogr D50:760–763
12. Wlodek S, Skillman AG, Nicholls A (2006) Automated ligand
placement and reﬁnement with a combined force ﬁeld and shape
potential. Acta Crystallogr D62:741–749
13. Emsley P, Cowtan K (2004) Coot: model-building tools for
molecular graphics. Acta Crystallogr D60:2126–2132
J Comput Aided Mol Des (2012) 26:497–503 503
123